By Josh Beckerman
Shares of Disc Medicine Inc., a biopharmaceutical institution focused connected hematology, roseate 32% to $17.81 connected the archetypal trading time aft a merger.
Nasdaq-listed Gemini Therapeutics Inc. combined with privately held Disc Medicine Inc. As portion of the merger close, Gemini effected a 1-for-10 reverse split.
Disc said it has astir $175 cardinal of currency and currency equivalents, providing operating runway into 2025.
Write to Josh Beckerman astatine josh.beckerman@wsj.com
English (US)